General neurologist · Johns Hopkins · United States (US) · Neurology
Data minimisation
Cadence target for Tier 2: 2 per year (assumption)
0 of 1 expected engagements
No insights captured from engagements with this stakeholder.
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 07 Feb 2026 | Investigator meeting | Virtual | James Whitfield | Lumeva | Dosing in hepatic impairment | 0 | — | Reviewed | ENG-0199 |
07 Feb 2026
Dosing in hepatic impairment
Johns Hopkins
Radiation oncologist
Thoracic medical oncologist
Primary care physician
Allergist
Dermatologist